RxDoctor Payments Data

Michel Torbey, MD

Neurocritical Care · Columbus, OHNPI 1679524326

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,930 of the $18,440 with a category attached, or 86.4%. Ceribell, Inc. accounts for 74.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $9,450 and has fallen 99.8% since, to $15 in 2025. Among neurocritical care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,440in general payments, 2019–2025

Across 6 payments — averaging $3073.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ceribell, Inc.$14K
  • Neurelis, Inc.$5K
  • Integra Lifesciences Corporation$15
$150,949in research payments, 2019–2025

Across 35 payments — averaging $4312.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$90K
  • Biogen$39K
  • C. R. Bard, Inc. & Subsidiaries$21K
  • BD$475

What the payments were for

  • Consulting fees$15,93086%
  • Speaking & faculty fees$2,40013%
  • Food & beverage$1101%

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,440 in reported general payments places this provider in the 95th percentile of 30 neurocritical care providers in Ohio.

See all neurocritical care providers in Ohio

Medicare billing

Part B allowed, 2024
$17,953
Medicare patients
38
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurocritical care in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →